Current
Neuro-Oncology


Volume 21 Number 6
June 2019


Home > Disciplines > Publications > Current Neuro-Oncology > Volume 21, Year 2019 > Number 6, June


CONTENTS


CENTRAL NERVOUS SYSTEM TUMORS

GLIOMAS
BRAIN STEM GLIOMAS
DIFFUSE MIDLINE GLIOMAS
HIGH-GRADE GLIOMAS
LOW-GRADE GLIOMAS

DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
GLIOBLASTOMA

EMBRYONAL TUMORS
MEDULLOBLASTOMA

LYMPHOMAS

METASTATIC TUMORS





CENTRAL NERVOUS SYSTEM TUMORS

.

Deopujari CE, Shah NJ, Shaikh ST, Karmarkar VS, Mohanty CB.
Endonasal endoscopic skullbase surgery in children.
Childs Nerv Syst. 2019 May 12. doi: 10.1007/s00381-019-04167-3. [Epub ahead of print]
Source | Full text | Similar articles



.

Vladoiu MC, El-Hamamy I, Donovan LK, Farooq H, Holgado BL, Sundaravadanam Y, Ramaswamy V, Hendrikse LD, Kumar S, Mack SC, Lee JJY, Fong V, Juraschka K, Przelicki D, Michealraj A, Skowron P, Luu B, Suzuki H, Morrissy AS, Cavalli FMG, Garzia L, Daniels C, Wu X, Qazi MA, Singh SK, Chan JA, Marra MA, Malkin D, Dirks P, Heisler L, Pugh T, Ng K, Notta F, Thompson EM, Kleinman CL, Joyner AL, Jabado N, Stein L, Taylor MD.
Childhood cerebellar tumours mirror conserved fetal transcriptional programs.
Nature. 2019 May 1. doi: 10.1038/s41586-019-1158-7. [Epub ahead of print]
Source | Full text | Similar articles



.

Zaazoue MA, Manley PE, Kapur K, Ullrich NJ, Silvera VM, Goumnerova LC.
Natural History and Management of Incidentally Discovered Focal Brain Lesions Indeterminate for Tumor in Children.
Neurosurgery. 2019 Apr 15. pii: nyz078. doi: 10.1093/neuros/nyz078. [Epub ahead of print]
Source | Full text | Similar articles



GLIOMAS



BRAIN STEM GLIOMAS




DIFFUSE MIDLINE GLIOMAS


.

Sun Y, Sun Y, Yan K, Li Z, Xu C, Geng Y, Pan C, Chen X, Zhang L, Xi Q.
Potent anti-tumor efficacy of palbociclib in treatment-naïve H3.3K27M-mutant diffuse intrinsic pontine glioma.
EBioMedicine. 2019 May;43:171-179. doi: 10.1016/j.ebiom.2019.04.043. Epub 2019 May 3.
Source | Full text | Similar articles



HIGH-GRADE GLIOMAS


.

Jethanandani A, Gule-Monroe MK, Chen M, Johnson JM.
Extraneural Metastases From a High-Grade Glioma (HGG) With an H3F3A G34R Mutation.
Front Oncol. 2019 May 8;9:373. doi: 10.3389/fonc.2019.00373. eCollection 2019.
Source | Full text | Similar articles



.

Tsang DS, Oliveira C, Bouffet E, Hawkins C, Ramaswamy V, Yee R, Tabori U, Bartels U, Huang A, Millar BA, Crooks B, Bowes L, Zelcer S, Laperriere N.
Repeat irradiation for children with supratentorial high-grade glioma.
Pediatr Blood Cancer. 2019 Jun 17:e27881. doi: 10.1002/pbc.27881. [Epub ahead of print]
Source | Full text | Similar articles



.

Tzaridis T, Gepfner-Tuma I, Hirsch S, Skardelly M, Bender B, Paulsen F, Schaub C, Weller J, Schäfer N, Herrlinger U, Tabatabai G.
Regorafenib in advanced high-grade glioma: a retrospective bicentric analysis.
Neuro Oncol. 2019 Apr 23. pii: noz071. doi: 10.1093/neuonc/noz071. [Epub ahead of print]
Source | Full text | Similar articles



LOW-GRADE GLIOMAS


.

Bouffet E.
Selumetinib in paediatric low-grade glioma: a new era?
Lancet Oncol. 2019 May 28. pii: S1470-2045(19)30304-3. doi: 10.1016/S1470-2045(19)30304-3. [Epub ahead of print]
Source | Full text | Similar articles
Comment on: Fangusaro J, et al, Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol. 2019 May 28. doi: 10.1016/S1470-2045(19)30277-3. Source / Full text



.

Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M.
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Lancet Oncol. 2019 May 28. pii: S1470-2045(19)30277-3. doi: 10.1016/S1470-2045(19)30277-3. [Epub ahead of print]
Source | Full text | Similar articles



.

Jairam V, Kann BH, Park HS, Miccio JA, Beckta JM, Yu JB, Prabhu RS, Gao SJ, Mehta MP, Curran WJ, Bindra RS, Contessa JN, Patel KR.
Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis.
Anticancer Res. 2019 Jun;39(6):2911-2918. doi: 10.21873/anticanres.13420.
Source | Full text | Similar articles



.

Rossi M, Ambrogi F, Gay L, Gallucci M, Conti Nibali M, Leonetti A, Puglisi G, Sciortino T, Howells H, Riva M, Pessina F, Navarria P, Franzese C, Simonelli M, Rudà R, Bello L.
Is supratotal resection achievable in low-grade gliomas? Feasibility, putative factors, safety, and functional outcome.
J Neurosurg. 2019 May 17:1-14. doi: 10.3171/2019.2.JNS183408. [Epub ahead of print]
Source | Full text | Similar articles



.

Tabrizi S, Yeap BY, Sherman JC, Nachtigall LB, Colvin MK, Dworkin M, Fullerton BC, Daartz J, Royce TJ, Oh KS, Batchelor TT, Curry WT, Loeffler JS, Shih HA.
Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma.
Radiother Oncol. 2019 May 10;137:95-101. doi: 10.1016/j.radonc.2019.04.027. [Epub ahead of print]
Source | Full text | Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS



GLIOBLASTOMA


.

Alimohammadi E, Bagheri SR, Salehi AS, Rizevandi P, Rezaie Z, Abdi A.
Prognostic factors in patients with glioblastoma multiforme: focus on the pathologic variants.
Acta Neurol Belg. 2019 Jun 20. doi: 10.1007/s13760-019-01171-x. [Epub ahead of print]
Source | Full text | Similar articles



.

Amsbaugh MJ, Yusuf M, Gaskins J, Burton E, Woo S.
The impact of timing of adjuvant therapy on survival for patients with glioblastoma: An analysis of the National Cancer Database.
J Clin Neurosci. 2019 May 16. pii: S0967-5868(18)31822-8. doi: 10.1016/j.jocn.2019.05.013. [Epub ahead of print]
Source | Full text | Similar articles



.

Cuncannon M, Wong M, Jayamanne D, Guo L, Cove N, Wheeler H, Back M.
Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma.
BMC Cancer. 2019 May 14;19(1):445. doi: 10.1186/s12885-019-5678-1.
Source | Full text | Similar articles



.

Forte IM, Indovina P, Iannuzzi CA, Cirillo D, Di Marzo D, Barone D, Capone F, Pentimalli F, Giordano A.
Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide.
Int J Oncol. 2019 Jun;54(6):2189-2199. doi: 10.3892/ijo.2019.4788. Epub 2019 Apr 16.
Source | Full text | Similar articles



.

Guzauskas GF, Pollom EL, Stieber VW, Wang BCM, Garrison LP Jr.
Tumor treating fields and maintenance temozolomide for newly-diagnosed glioblastoma: a cost-effectiveness study.
J Med Econ. 2019 May 3:1-8. doi: 10.1080/13696998.2019.1614933. [Epub ahead of print]
Source | Full text | Similar articles



.

Jiang H, Zeng W, Ren X, Cui Y, Li M, Yang K, Elbaroody M, Lin S.
Super-early initiation of temozolomide prolongs the survival of glioblastoma patients without gross-total resection: a retrospective cohort study.
J Neurooncol. 2019 Jun 7. doi: 10.1007/s11060-019-03211-1. [Epub ahead of print]
Source | Full text | Similar articles



.

Jin MC, Wu A, Xiang M, Azad TD, Soltys SG, Li G, Pollom EL.
Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma.
World Neurosurg. 2019 Apr 19. pii: S1878-8750(19)31097-6. doi: 10.1016/j.wneu.2019.04.103. [Epub ahead of print]
Source | Full text | Similar articles



.

Jo Y, Sung J, Jeong H, Hong S, Jeong YK, Kim EH, Yoon M.
Effectiveness of a Fractionated Therapy Scheme in Tumor Treating Fields Therapy.
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819845008. doi: 10.1177/1533033819845008.
Source | Full text | Similar articles



.

Katsigiannis S, Krischek B, Barleanu S, Grau S, Galldiks N, Timmer M, Kabbasch C, Goldbrunner R, Stavrinou P.
Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma.
Radiat Oncol. 2019 Apr 29;14(1):73. doi: 10.1186/s13014-019-1272-6.
Source | Full text | Similar articles



.

Kim MM, Speers C, Li P, Schipper M, Junck L, Leung D, Orringer D, Heth J, Umemura Y, Spratt DE, Wahl DR, Cao Y, Lawrence TS, Tsien CI.
Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma.
J Neurooncol. 2019 Jun;143(2):313-319. doi: 10.1007/s11060-019-03166-3. Epub 2019 Apr 11.
Source | Full text | Similar articles



.

Mahzouni P, Shavakhi M.
Prostate-Specific Membrane Antigen Expression in Neovasculature of Glioblastoma Multiforme.
Adv Biomed Res. 2019 Feb 27;8:18. doi: 10.4103/abr.abr_209_18. eCollection 2019.
Source | Full text | Similar articles |



.

Marafi F, Sasikumar A, Fathallah W, Esmail A.
18F-PSMA 1007 Brain PET/CT Imaging in Glioma Recurrence.
Clin Nucl Med. 2019 Jun 1. doi: 10.1097/RLU.0000000000002668. [Epub ahead of print]
Source | Abstract | Similar articles



.

Tamai S, Kinoshita M, Sabit H, Furuta T, Miyashita K, Yoshimura K, Homma T, Harada K, Nakada M.
Case of metastatic glioblastoma with primitive neuronal component to the lung.
Neuropathology. 2019 Jun;39(3):218-223. doi: 10.1111/neup.12553. Epub 2019 Apr 25.
Source | Full text | Similar articles



EMBRYONAL TUMORS



MEDULLOBLASTOMA


.

Gupta T, Maitre M, Sastri GJ, Krishnatry R, Shirsat N, Epari S, Sahay A, Chinnaswamy G, Patil V, Shetty P, Moiyadi A.
Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
J Neurooncol. 2019 Jun 24. doi: 10.1007/s11060-019-03225-9. [Epub ahead of print]
Source | Full text | Similar articles



.

Khalil J, Qing Z, Chuanying Z, Belkacémi Y, Benjaafar N, Mawei J.
Twenty years experience in treating childhood medulloblastoma: Between the past and the present.
Cancer Radiother. 2019 Jun;23(3):179-187. doi: 10.1016/j.canrad.2018.05.008. Epub 2019 May 18.
Source | Full text | Similar articles



.

Sweeney KJ, Mottolese C, Belot A, Szathmari A, Frappaz D, Lesca G, Putoux A, Di Rocco F.
The first case report of medulloblastoma associated with Tatton-Brown-Rahman syndrome.
Am J Med Genet A. 2019 Jul;179(7):1357-1361. doi: 10.1002/ajmg.a.61180. Epub 2019 May 7.
Source | Full text | Similar articles



.

Xia H, Zhong D, Wu X, Li J, Yang Y, Sun X.
Medulloblastomas in cerebellopontine angle: Epidemiology, clinical manifestations, imaging features, molecular analysis and surgical outcome.
J Clin Neurosci. 2019 Jun 22. pii: S0967-5868(18)31985-4. doi: 10.1016/j.jocn.2019.06.013. [Epub ahead of print]
Source | Full text | Similar articles



LYMPHOMAS

.

Neuhauser M, Roetzer T, Oberndorfer S, Kitzwoegerer M, Payer F, Unterluggauer JJ, Haybaeck J, Stockhammer G, Iglseder S, Moser P, Thomé C, Stultschnig M, Wuertz F, Brandner-Kokalj T, Weis S, Bandke D, Pichler J, Hutterer M, Krenosz KJ, Boehm A, Mayrbaeurl B, Hager-Seifert A, Kaufmann H, Dumser M, Reiner-Concin A, Hoenigschnabl S, Kleindienst W, Hoffermann M, Dieckmann K, Kiesel B, Widhalm G, Marosi C, Jaeger U, Hainfellner A, Hackl M, Hainfellner JA, Preusser M, Woehrer A.
Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.
Acta Oncol. 2019 Apr 17:1-10. doi: 10.1080/0284186X.2019.1599137. [Epub ahead of print]
Source | Full text | Similar articles



METASTATIC TUMORS

.

Munoz-Bendix C, Rapp M, Mijderwijk HJ, von Sass C, Dibué-Adjei M, Cornelius JF, Steiger HJ, Turowski B, Sabel M, Kamp MA.
Risk factors for in-brain local progression in elderly patients after resection of cerebral metastases.
Sci Rep. 2019 May 15;9(1):7431. doi: 10.1038/s41598-019-43942-9.
Source | Full text | Similar articles



bottom



***